Abstract
This review offers a summary of the current knowledge of pshychotropic drugs and glaucoma. If exposed to psychotropic drugs, some patients may develop angle-closure glaucoma. Although rarely contraindicated, exposed predisposed and diagnosed patients should be followed-up by an ophthalmologist. It is still unclear if serotonin reuptake inhibitors increase the risk of angle-closure glaucoma. Tricyclic antidepressants and benzodiazepines should be used with caution in predisposed patients. The same applies to antipsychotic drugs, where first-generation antipsychotic drugs might have a smaller impact on the intraocular pressure than second-generation antipsychotic drugs.
| Bidragets oversatte titel | Psychotropic drugs for patients with glaucoma |
|---|---|
| Originalsprog | Dansk |
| Artikelnummer | V03230141 |
| Tidsskrift | Ugeskrift for Laeger |
| Vol/bind | 185 |
| Udgave nummer | 48 |
| ISSN | 0041-5782 |
| Status | Udgivet - 27 nov. 2023 |
Emneord
- Humans
- Antipsychotic Agents/adverse effects
- Glaucoma, Angle-Closure/chemically induced
- Psychotropic Drugs
- Glaucoma/chemically induced
- Selective Serotonin Reuptake Inhibitors/adverse effects
Fingeraftryk
Dyk ned i forskningsemnerne om 'Psykofarmaka til patienter med glaukom'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS